Evidence map›Paper›PMID 35451185›Full record

ArticleJournal of cellular and molecular medicine2022

Identification of optimal reference genes for gene expression studies in a focal cerebral ischaemia model-Spatiotemporal effects.

Bartosz Pomierny, Weronika Krzyzanowska, Jakub Jurczyk, Beata Strach, Alicja Skorkowska, Innesa Leonovich, Bogusława Budziszewska, Joanna Pera

Open access · goldAbstract read
In one paragraph

Article in Journal of cellular and molecular medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Bartosz PomiernyDepartment of Toxicological Biochemistry, Faculty of Pharmacy, Jagiellonian University Medical College, Kraków, Poland.ORCID 0000-0002-5352-5324
Weronika KrzyzanowskaDepartment of Toxicological Biochemistry, Faculty of Pharmacy, Jagiellonian University Medical College, Kraków, Poland.
Jakub JurczykDepartment of Toxicological Biochemistry, Faculty of Pharmacy, Jagiellonian University Medical College, Kraków, Poland.
Beata StrachDepartment of Neurology, Faculty of Medicine, Jagiellonian University Medical College, Kraków, Poland.
Alicja SkorkowskaDepartment of Toxicological Biochemistry, Faculty of Pharmacy, Jagiellonian University Medical College, Kraków, Poland.
Innesa LeonovichDepartment of Toxicological Biochemistry, Faculty of Pharmacy, Jagiellonian University Medical College, Kraków, Poland.
Bogusława BudziszewskaDepartment of Toxicological Biochemistry, Faculty of Pharmacy, Jagiellonian University Medical College, Kraków, Poland.
Joanna PeraDepartment of Neurology, Faculty of Medicine, Jagiellonian University Medical College, Kraków, Poland.ORCID 0000-0001-6142-2969
Jagiellonian University · PL

Funding

European Commission POWR.03.02.00-00-I013/16National Science Center in Poland 2016/21/B/NZ4/03294National Science Center in Poland 2016/21/D/NZ4/03302
6 · The paper itself

Abstract

A proper reference gene (RG) is required to reliably measure mRNA levels in biological samples via quantitative reverse transcription PCR (RT-qPCR). Various experimental paradigms require specific and stable RGs. In studies using rodent models of brain ischaemia, a variety of genes, such as β-actin (Actb), hypoxanthine phosphoribosyltransferase 1 (Hprt1), peptidyl-propyl isomerase A (Ppia) and glyceraldehyde-3-phosphate dehydrogenase (Gapdh), are used as RGs. However, most of these genes have not been validated in specific experimental settings. The aim of this study was to evaluate the time- and brain region-dependent expression of RG candidates in a rat model of transient middle cerebral artery occlusion (tMCAO). The following genes were selected: Actb, Hprt1, Ppia, Gapdh, tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta (Ywhaz) and beta-2 microglobulin (B2m). Focal cerebral ischaemia was induced by 90 min of tMCAO in male Sprague-Dawley rats. Expression was investigated at four time points (12 and 24 h; 3 and 7 days) and in three brain areas (the frontal cortex, hippocampus and dorsal striatum) within the ischaemic brain hemisphere. The RT-qPCR results were analysed using variance analysis and the ΔCt, GeNorm, NormFinder and BestKeeper methods. Data from these algorithms were ranked using the geometric mean of ranks of each analysis. Ppia, Hprt1 and Ywhaz were the most stable genes across the analysed brain areas and time points. B2m and Actb exhibited the greatest fluctuations, and the results for Gapdh were ambiguous.

Indexed as

Brain IschemiaGlyceraldehyde-3-Phosphate DehydrogenasesActinsAnimalsGene ExpressionGene Expression ProfilingMaleRatsRats, Sprague-DawleyReal-Time Polymerase Chain ReactionReference StandardsActinsGlyceraldehyde-3-Phosphate Dehydrogenasesbrain ischaemiareference genesRT-PCRtransient middle cerebral artery occlusion

Identifiers

PMID35451185
PMCPMC9097850
OpenAlexW4224224478

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.